I’m sorry to hear your CPAP mask is keeping you awake at night, but I’m happy to hear that you’re addressing your obstructive ...

LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary ...

Researchers determine the differential risk of dementia among men and women based on the presence of obstructive sleep apnea.

Doctor Viorrito says, “Sleep apnea, especially in our school aged children can look exactly like ADHD.” A report from the ...

LivaNova (LIVN) “announced that it met the primary endpoints for its OSPREY randomized controlled trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation. Together with ...

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

Obstructive sleep apnea (OSA) contributes to dementia risk in older adults, particularly women, according to a study ...

Researchers have identified that children deficient in vitamin D experience more severe symptoms of obstructive sleep apnea ...

Bryan Vadney, an Army Veteran used to love life, being active, spending time with family and friends and taking part in his ...

Needham analyst Michael Matson has maintained their bullish stance on LIVN stock, giving a Buy rating on October 31. Michael Matson has given ...

This could lead to FDA approvals for treatment in obstructive sleep apnea, kidney disease, Alzheimer’s disease, liver disease ...